Sin­ga­pore can­cer cell ther­a­py start­up Tes­sa Ther­a­peu­tics to shut down

Tes­sa Ther­a­peu­tics, a Sin­ga­pore-based can­cer cell ther­a­py start­up backed by the likes of Temasek and Po­laris Part­ners, will shut down, a per­son fa­mil­iar with the sit­u­a­tion con­firmed to End­points News. Lo­cal me­dia re­ports had emerged in re­cent days say­ing the biotech had failed to raise ad­di­tion­al funds.

A spokesper­son con­firmed the shut­down in an email to End­points. “Con­sid­er­able de­bate and con­sid­er­a­tion” went in­to the de­ci­sion, the spokesper­son said, not­ing the start­up is “in dis­cus­sions with a third par­ty re­gard­ing con­tin­ued op­er­a­tions” of its man­u­fac­tur­ing fa­cil­i­ty TSMO.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER